• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Overdiagnosis in Psychiatry

Overdiagnosis in Psychiatry

September 10, 2021
Joel Paris, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Joel Paris, MDJoel Paris, MD

Professor emeritus at McGill University, and senior psychiatrist and research associate at Sir Mortimer B. Davis-Jewish General Hospital. Dr. Paris is the former editor of the Canadian Journal of Psychiatry and the author of 25 books including Overdiagnosis in Psychiatry, 2nd ed. (Oxford University Press; 2020). Dr. Paris has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

TCPR: Which disorders are the most overdiagnosed in psychiatry?
Dr. Paris: At the top of the list are major depression, PTSD, bipolar II, adult ADHD, and—this one is a recent addition because it used to be underdiagnosed—borderline personality disorder. Each of these conditions may be underdiagnosed in some settings as well, but they have also been pushed toward diagnostic expansion.

TCPR: That sounds like a lot of my patients. What are we doing wrong?
Dr. Paris: Part of the problem is not using the DSM criteria. Many clinicians are rushed, and the criteria are difficult to memorize. Nearly half of patients whose primary care provider diagnosed them with depression don’t actually meet the DSM criteria for it (Mojtabai R, Psychother Psychosom 2013;82(3):161–169). But even if the criteria are used, the DSM still has a pretty low bar for major depression. In reality, depression is a universal phenomenon that is on a continuum, and you make a slice somewhere. But where you make that slice is not really evidence based.

TCPR: When you say “a low bar for depression,” what do you mean?
Dr. Paris: The two-week cutoff was a big mistake. Lots of people have depression that self-resolves after a few weeks. If the DSM had said six or seven weeks, I think we’d be in less trouble. Another problem is that the DSM lumps both mild and severe cases under the diagnostic umbrella of “major depressive disorder.” That was not the case before 1980 with DSM-III, and there are reasons to separate mild and severe cases. We know, for example, that antidepressants don’t separate very well from placebo in mild cases—their efficacy is only undisputed in severe depression (Fournier JC et al, JAMA 2010;303(1):47–53). Treating everyone who meets criteria for major depression with an antidepressant is simply not evidence based. The UK has stepped away from this with the NICE guidelines, which do not recommend antidepressants for mild depression. But the APA and Canadian guidelines still allow it.

TCPR: Do clinicians in the UK use psychotherapy for mild depression?
Dr. Paris: Yes, and patients there have better access to it because the British hired psychologists to bring cognitive behavioral therapy (CBT) for anxiety and depression into the National Health Service.

PTSD, Bipolar Disorder, and ADHD


TCPR: How is PTSD overdiagnosed?
Dr. Paris: PTSD has a big problem with criterion A, which requires the presence of a trauma. Originally the patient had to experience or witness the trauma, but now just hearing about a traumatic event is enough to meet the criterion. And PTSD is a diagnosis beloved not only by clinicians, but by patients too. They actually want to have PTSD because it means somebody else is at fault, not them, and they’re a victim.

TCPR: How is bipolar disorder overdiagnosed?
Dr. Paris: The problem is not with standard bipolar I. That kind of mania is unmistakable. But bipolar II only came in with DSM-IV, and the criteria are kind of fuzzy. I think clinicians reach for their prescription pad when they see mood swings of any kind because they think they’re seeing a case of bipolar II. Mark Zimmerman showed that patients who screen positive for bipolar disorder on the Mood Disorder Questionnaire are just as likely to have borderline personality disorder as they are to have bipolar on closer examination (Zimmerman M et al, J Pers Disord 2019;33(4):533–543). Mood swings are a key feature of borderline personality disorder, and that can confuse the picture for many clinicians.

TCPR: And ADHD?
Dr. Paris: That diagnosis has gone up dramatically in the last 20 years in adults and children. Ten times as many people are taking stimulant drugs compared to a couple of decades ago. Nearly one in five adolescent boys are diagnosed with ADHD (Visser SN et al, J Am Acad Child Adolesc Psychiatry 2014;53(1):34–46). Adult ADHD used to be rare, but in the National Comorbidity Survey the rate was one in 23, and that was while using the childhood-onset requirement, which is often ignored in practice (Kessler RC et al, Am J Psychiatry 2006;163(4):716–723). Previously, symptoms had to start before age 7 to make a diagnosis, and then DSM-5 extended that to age 12.

TCPR: We are seeing adults present with symptoms of ADHD but no evidence of the disorder in childhood. What could be causing that?
Dr. Paris: Patients with “adult ADHD” have a lot of psychiatric comorbidities that could explain their cognitive problems. Problems with attention and executive functioning are well documented in mood, anxiety, personality, sleep, and substance use disorders (Paris J. Overdiagnosis in Psychiatry. New York, NY: Oxford University Press; 2020). Terrie Moffitt’s group followed a New Zealand birth cohort for 40 years and found that most people who had symptoms of ADHD in adulthood did not have those symptoms as children (Agnew-Blais JC et al, JAMA Psychiatry 2016;73(7):713–720). This suggests that the symptoms do not have the same etiology as true ADHD.

TCPR: The problem with age of onset in that study does cast doubt on the concept of adult ADHD. But the study ended up having a different effect. It generated a lot of headlines announcing the discovery of a new diagnosis: adult-onset ADHD.
Dr. Paris: Well, Dr. Moffitt did open the door for this in her article, but I would say, “Why call it ADHD?” In the Moffitt study, most of the patients with “adult-onset ADHD” had a history of mood, conduct, or substance use disorders that might have explained their adult ADHD symptoms. Another problem with ADHD is the inclusion of the inattentive subtype, which took place with DSM-IV in 1994.

TCPR: What is the problem with inattentive ADHD?
Dr. Paris: It opened the door to overdiagnosis. Now almost anybody who is troubled can come up with a story about their inattention, and they do. Hyperactivity is more observable, so it’s harder to overdiagnose, and our research is most robust with the hyperactive types. We know what these patients are at risk for later on—things like substance use and antisocial behavior.

Underdiagnosis in Schizophrenia


TCPR: If some disorders are overdiagnosed, are others underdiagnosed?
Dr. Paris: Schizophrenia is probably underdiagnosed. I think the problem there is not with the definition (although the overlap with bipolarity is still pretty controversial), but with its difficult prognosis. I think clinicians would rather call it schizoaffective disorder, which has a better prognosis because it lacks the negative symptoms, or just nonspecific psychosis. However, there has been a movement to recognize early signs of schizophrenia, and that is changing things.

TCPR: How so?
Dr. Paris: The idea is that if you recognize prodromal signs and intervene early, you may be able to obviate that bad prognosis. Early intervention proponents haven’t proven their case completely at all, but they have helped shift the perspective. Interestingly, the evidence is stronger for CBT than it is for antipsychotics when it comes to preventing schizophrenia in youth at risk (Nelson B and McGorry P, Child Adolesc Psychiatr Clin N Am 2020;29(1):57–69).

Borderline Personality Disorder


TCPR: What is lost by missing a personality disorder?
Dr. Paris: Outcomes are not as good. Whether it’s pharmacotherapy, psychotherapy, or even electroconvulsive therapy, a lot of research shows that people with personality disorders do not do as well when given standard treatments for other disorders. These patients require more specialized methods.

TCPR: Which personality disorders are most important to recognize in practice?
Dr. Paris: Borderline and antisocial. Those are the only ones that have serious research behind them. We have a good etiological theory for borderline personality disorder. Emotional dysregulation is a heritable trait that is then amplified by an invalidating environment. There’s more to the theory, but that explanation captures its essence, and it was one of Marsha Linehan’s greatest contributions.

TCPR: What is an invalidating environment?
Dr. Paris: It refers to growing up in a situation where your family isn’t interested in your emotions. “Emotional dysregulation” means a patient is unusually sensitive—they have “thin skin” and high neuroticism, where everything bothers them and they can’t calm down. And that is a highly heritable trait. If they grow up in an environment where somebody around them says, “I understand how you feel. You have every right to feel that way. Let’s figure out how you can get past this. You know how to calm yourself and think of a way to solve the problem,” then it doesn’t turn out so bad. But what patients with borderline personality disorder describe to me is, “Nobody was interested in my feelings. I was told to buck up, get over it, and not make a big deal out of it.”

TCPR: So it’s not necessarily trauma that causes it.
Dr. Paris: Correct. One of the great myths about borderline personality disorder is that it’s due to trauma. While trauma is common in borderline personality disorder, fewer than half the cases actually have a significant history of trauma. Often, when you take a closer look at a patient’s history, you’ll find they had evidence of a personality disorder before the trauma, and borderline personality disorder affects judgment, impulsivity, and relationships in ways that can put people at risk for trauma (Paris J. Treatment of Borderline Personality Disorder. 2nd ed. New York, NY: Guilford Press; 2020).

TCPR: Some have suggested that cyclothymia is the underlying temperament behind borderline personality disorder.
Dr. Paris: I think emotional dysregulation is a more accurate term. Cyclothymic disorder involves frequent mood cycles—hypomania, depression, mixed states. But moods last longer than emotional dysregulation. Patients will describe it like this: “I get upset and I blow sky high. It takes me hours to calm down.” And this is nothing like hypomania, which is a consistent state of high energy and irritable or elevated mood for four days or more. With emotional dysregulation, the symptoms usually come on as a direct reaction to an interpersonal stress. This persists for a few hours and then the patient sleeps it off, and the next day something else happens.

TCPR: You mentioned that borderline personality disorder used to be underdiagnosed, but now that’s changing.
Dr. Paris: Yes, and this gets back to prognosis. People used to think borderline personality disorder was incurable, but now that we have effective treatments for it like DBT and other psychotherapies, I’m having to tell patients, “No, you actually don’t have borderline personality disorder” and they’re disappointed.

TCPR: How would you explain to a patient that they don’t have a psychiatric disorder or that their problems are not severe enough to warrant medication?
Dr. Paris: Some people might be relieved to hear that, while others might be outraged. I think it depends on how they see themselves. One of my colleagues at McLean Hospital described something she called “emotional hypochondriasis” where people feel that their psychology is sick and they hold onto that as a kind of identity. So this is a complicated question. I tell residents, “Some people are going to walk out of here mad, and you’ll have to get used to it.” But I don’t have a simple answer.

TCPR: Thank you for your time, Dr. Paris.

 


Podcast Episode: Listen to more on overdiagnosis.
Experts in borderline personality disorder and bipolar disorder reach a consensus about the mercurial temperament that underlies borderline personality. The DSM Committee restores a diagnostic code to recognizes those with a “clean bill of mental health,” and the word of the day goes psychedelic over the 5-HT2A receptor.

Click here for full episode notes and transcript.


 
General Psychiatry
KEYWORDS adult-adhd bipolar-ii borderline-personality-disorder bpd diagnosis dsm ptsd stigma
    Headshot qa joel paris 150x150
    Joel Paris, MD

    Diagnosing and Treating Borderline Personality Disorder

    More from this author
    www.thecarlatreport.com
    Issue Date: September 10, 2021
    SUBSCRIBE NOW
    Table Of Contents
    Genetic Testing in Depression
    Desert Island Diagnoses
    Atomoxetine: Myths and Truths
    Overdiagnosis in Psychiatry
    Psilocybin vs Escitalopram for Depression
    Pilot Study of Ketamine vs ECT for Major Depression
    CME Post-Test - Overdiagnosis, TCPR, September 2021
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.